Clinical Trials Directory

Trials / Sponsors / Protein Sciences Corporation

Protein Sciences Corporation

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
CompletedPost-Marketing Observational Study of Safety Following Vaccination With Flublok® Compared to Licensed IIV in A
Human Influenza
—2015-11-01
CompletedTrial to Evaluate the Immunogenicity and Safety of Panblok® (H7 rHA) in Healthy Adults Aged 18 and Older
Influenza
Phase 1 / Phase 22015-07-01
CompletedSafety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age
Influenza
Phase 32014-10-01
CompletedProtective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years
Influenza
Phase 32014-10-01
CompletedSafety, Reactogenicity and Immunogenicity of Flublok Quadrivalent (Recombinant Influenza Vaccine,Seasonal Form
Influenza
Phase 32013-11-01
CompletedComparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age
Influenza
Phase 32013-03-01
CompletedSafety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults
Influenza
Phase 1 / Phase 22012-05-01
CompletedSafety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults
Influenza
Phase 1 / Phase 22010-06-01
CompletedSafety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV
Influenza
Phase 32007-09-01
CompletedComparison of the Immunogenicity, Safety and Reactogenicity of FluBlok, To a Licensed Vaccine In Elderly Adult
Influenza
Phase 32006-10-01
CompletedImmunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatri
Influenza
Phase 1 / Phase 22006-10-01
CompletedImmunogenicity and Safety of Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Adults
Influenza
Phase 2 / Phase 32004-11-01